198 related articles for article (PubMed ID: 28859389)
1. Impacts of treatments on the quality of life among esophageal squamous cell carcinoma patients.
Chen CY; Hsieh VC; Chang CH; Chen PR; Liang WM; Pan SC; Shieh SH
Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859389
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in long-term survivors after high-dose chemoradiotherapy followed by surgery in esophageal cancer.
Hurmuzlu M; Aarstad HJ; Aarstad AK; Hjermstad MJ; Viste A
Dis Esophagus; 2011 Jan; 24(1):39-47. PubMed ID: 20819100
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life and treatment modality among esophageal squamous cell carcinoma survivors: A prospective study using time to deterioration model analysis.
Liu S; Lin Z; Lin J; Chen H; Xie Q; Rao W; Chen Y; Yu K; Hu Z
J Surg Oncol; 2021 Jan; 123(1):156-163. PubMed ID: 33126290
[TBL] [Abstract][Full Text] [Related]
5. Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial.
Noordman BJ; Verdam MGE; Lagarde SM; Shapiro J; Hulshof MCCM; van Berge Henegouwen MI; Wijnhoven BPL; Nieuwenhuijzen GAP; Bonenkamp JJ; Cuesta MA; Plukker JTM; Spillenaar Bilgen EJ; Steyerberg EW; van der Gaast A; Sprangers MAG; van Lanschot JJB;
Ann Oncol; 2018 Feb; 29(2):445-451. PubMed ID: 29126244
[TBL] [Abstract][Full Text] [Related]
6. Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial.
Noordman BJ; Verdam MGE; Lagarde SM; Hulshof MCCM; van Hagen P; van Berge Henegouwen MI; Wijnhoven BPL; van Laarhoven HWM; Nieuwenhuijzen GAP; Hospers GAP; Bonenkamp JJ; Cuesta MA; Blaisse RJB; Busch OR; Ten Kate FJW; Creemers GM; Punt CJA; Plukker JTM; Verheul HMW; Spillenaar Bilgen EJ; van Dekken H; van der Sangen MJC; Rozema T; Biermann K; Beukema JC; Piet AHM; van Rij CM; Reinders JG; Tilanus HW; Steyerberg EW; van der Gaast A; Sprangers MAG; van Lanschot JJB
J Clin Oncol; 2018 Jan; 36(3):268-275. PubMed ID: 29161204
[TBL] [Abstract][Full Text] [Related]
7. Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
Lin WC; Ding YF; Hsu HL; Chang JH; Yuan KS; Wu ATH; Chow JM; Chang CL; Chen SU; Wu SY
Cancer; 2017 Oct; 123(20):3904-3915. PubMed ID: 28608916
[TBL] [Abstract][Full Text] [Related]
8. Translation, validation of the EORTC esophageal cancer quality-of-life questionnaire for Japanese with esophageal squamous cell carcinoma: analysis in thoraco-laparoscopic esophagectomy versus open esophagectomy.
Fujita T; Okada N; Sato T; Mayanagi S; Kanamori J; Daiko H
Jpn J Clin Oncol; 2016 Jul; 46(7):615-21. PubMed ID: 27056967
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients.
Chen CY; Li CC; Chien CR
World J Surg Oncol; 2018 Jul; 16(1):141. PubMed ID: 30007409
[TBL] [Abstract][Full Text] [Related]
10. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer.
Blazeby JM; Conroy T; Hammerlid E; Fayers P; Sezer O; Koller M; Arraras J; Bottomley A; Vickery CW; Etienne PL; Alderson D;
Eur J Cancer; 2003 Jul; 39(10):1384-94. PubMed ID: 12826041
[TBL] [Abstract][Full Text] [Related]
11. Patterns of recurrence after oesophagectomy and postoperative chemoradiotherapy versus surgery alone for oesophageal squamous cell carcinoma.
Hsu PK; Chen HS; Huang CS; Liu CC; Hsieh CC; Hsu HS; Wu YC; Wu SC
Br J Surg; 2017 Jan; 104(1):90-97. PubMed ID: 27859017
[TBL] [Abstract][Full Text] [Related]
12. Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.
Chang CL; Tsai HC; Lin WC; Chang JH; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
Radiother Oncol; 2017 Oct; 125(1):73-79. PubMed ID: 28923576
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus.
Uno T; Isobe K; Kawakami H; Ueno N; Shimada H; Matsubara H; Okazumi S; Nabeya Y; Shiratori T; Kawata T; Ochiai T; Ito H
Dis Esophagus; 2007; 20(1):12-8. PubMed ID: 17227304
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer.
Yoshii T; Ohkawa S; Tamai S; Kameda Y
Dis Esophagus; 2013 Jul; 26(5):496-502. PubMed ID: 22676622
[TBL] [Abstract][Full Text] [Related]
15. Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae.
Ma L; Luo GY; Ren YF; Qiu B; Yang H; Xie CX; Liu SR; Liu SL; Chen ZL; Li Q; Fu JH; Liu MZ; Hu YH; Ye WF; Liu H
Chin J Cancer; 2017 Jan; 36(1):8. PubMed ID: 28077159
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting survival in patients with advanced oesophageal cancer: a prospective multicentre evaluation.
Bergquist H; Johnsson A; Hammerlid E; Wenger U; Lundell L; Ruth M
Aliment Pharmacol Ther; 2008 Mar; 27(5):385-95. PubMed ID: 18081735
[TBL] [Abstract][Full Text] [Related]
17. Factors relating to quality of life after esophagectomy for cancer patients in Taiwan.
Chang YL; Tsai YF; Wu YC; Hsieh MJ
Cancer Nurs; 2014; 37(1):4-13. PubMed ID: 23357884
[TBL] [Abstract][Full Text] [Related]
18. Long-term quality of life after Ivor Lewis esophagectomy for esophageal cancer.
Däster S; Soysal SD; Stoll L; Peterli R; von Flüe M; Ackermann C
World J Surg; 2014 Sep; 38(9):2345-51. PubMed ID: 24756548
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in locally advanced cervical cancer patients treated with neoadjuvant therapy followed by radical surgery: A single-institutional retrospective study from a prospective database.
Liu B; Li L; Wang M; Wei L; Li J; Zou W; Lv Y; Zhang H; Liu S
Gynecol Oncol; 2019 Sep; 154(3):583-589. PubMed ID: 31307665
[TBL] [Abstract][Full Text] [Related]
20. Tumor length assessed by miniprobe endosonography can predict the survival of the advanced esophageal squamous cell carcinoma with stricture receiving concurrent chemoradiation.
Chang WL; Lin FC; Yen CJ; Cheng H; Lai WW; Yang HB; Sheu BS
Dis Esophagus; 2011 Nov; 24(8):590-5. PubMed ID: 21539673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
